In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.

It is noteworthy that the sales of chemical raw material medicine kept a fast growth and so did the Chinese traditional patent medicine. With the rising price of raw material medicine, the profit also grew rapidly. Besides, there is a sharp increase in the profit of chemical medicine and Chinese traditional patent medicine. Only the growth of the profit of biological medicine was slightly lower than that of the same period of 2006. Except for chemical preparation medicine, the profit margin of each subsidiary industry was all below the level of the year 2006 around, but higher than the same period of last year.

Monthly Sales Income and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007

Monthly Profits and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007

Statistical Production/Sales Ratio of Pharmaceutical Industry

2 Major Enterprises Analysis
2.1 Huarun-associated Enterprises
2.1.1 Sanjiu Medical & Pharmaceutical Co., Ltd.
2.1.2 Beijing Double-crane Pharmaceutical Co., Ltd.
2.1.3 Shanghai Pharmaceutical (Group) Co., Ltd.
2.1.3 Beijing Wandong Medical Equipment
2.2 Enterprises with Overall Listing
2.2.1 Beijing Tongrentang (Group) Co., Ltd.
2.2.2 Jiangsu Hengrui Medicine Co., Ltd.
2.2.3 East China Pharmaceutical Co., Ltd.
2.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd.
2.3 Small-category Raw Material Pharmaceutical Enterprises
2.3.1 Hubei Guangji Pharmaceutical Co., Ltd.
2.3.2 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
2.4 Others
2.4.1 Zhejiang Huahai Pharmaceutical Co., Ltd.
2.4.2 Shandong Dong-E E-jiao Co., Ltd.